Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Seer Inc Cl A (SEER)

Seer Inc Cl A (SEER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 116,715
  • Shares Outstanding, K 61,429
  • Annual Sales, $ 16,660 K
  • Annual Income, $ -86,280 K
  • EBIT $ -100 M
  • EBITDA $ -106 M
  • 60-Month Beta 1.45
  • Price/Sales 7.01
  • Price/Cash Flow N/A
  • Price/Book 0.33

Options Overview Details

View History
  • Implied Volatility 144.36% ( +25.65%)
  • Historical Volatility 44.84%
  • IV Percentile 58%
  • IV Rank 18.93%
  • IV High 693.04% on 12/13/23
  • IV Low 16.21% on 07/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 12
  • Volume Avg (30-Day) 13
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 500
  • Open Int (30-Day) 1,058

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.29
  • Number of Estimates 2
  • High Estimate -0.24
  • Low Estimate -0.34
  • Prior Year -0.33
  • Growth Rate Est. (year over year) +12.12%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.8200 +10.99%
on 10/24/24
2.0400 -0.98%
on 11/04/24
+0.0200 (+1.00%)
since 10/04/24
3-Month
1.5850 +27.44%
on 09/11/24
2.0400 -0.98%
on 11/04/24
+0.1800 (+9.78%)
since 08/02/24
52-Week
1.4550 +38.83%
on 11/16/23
2.3000 -12.17%
on 05/08/24
+0.2000 (+10.99%)
since 11/03/23

Most Recent Stories

More News
Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024

SEER : 2.0200 (+6.32%)
Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024

SEER : 2.0200 (+6.32%)
Seer to Report Third Quarter 2024 Financial Results on November 6, 2024

SEER : 2.0200 (+6.32%)
Why Shares of Seer Are Slumping Wednesday

The company reported a net loss but improved revenue in the second quarter.

SEER : 2.0200 (+6.32%)
DISCOVERY LIFE SCIENCES LAUNCHES WORLD-CLASS PROTEOMIC SERVICES DIVISION SUPPORTED BY LEADING TECHNOLOGY PARTNERS

/CNW/ -- Discovery Life Sciencesâ„¢ (Discovery) today announced the launch of its new Proteomic Services Division and is now accepting samples from...

SEER : 2.0200 (+6.32%)
DISCOVERY LIFE SCIENCES LAUNCHES WORLD-CLASS PROTEOMIC SERVICES DIVISION SUPPORTED BY LEADING TECHNOLOGY PARTNERS

/PRNewswire/ -- Discovery Life Sciencesâ„¢ (Discovery) today announced the launch of its new Proteomic Services Division and is now accepting samples from...

SEER : 2.0200 (+6.32%)
OLK : 26.08 (+0.31%)
Probius Emerges to Transform Data Acquisition for AI in Healthcare, adding John Baldoni, Chief Scientific Officer, and Juan C. Cuevas, SVP Marketing and Business Development

Probius, a deep tech company bridging the data gap between biology and AI, today announced the expansion of their leadership team. John Baldoni, PhD, has joined as Chief Scientific Officer, and Juan C....

SEER : 2.0200 (+6.32%)
TMO : 555.47 (-0.44%)
Seer, Inc. (SEER) Q2 2022 Earnings Call Transcript

SEER earnings call for the period ending June 30, 2022.

SEER : 2.0200 (+6.32%)
Seer Reports Second Quarter 2022 Financial Results

Company launches novel proteogenomics workflow with the Proteographâ„¢ Analysis Suite 2.0, further demonstrates the power of its technology with new customer...

SEER : 2.0200 (+6.32%)
Seer Launches First-of-its-kind Proteogenomics Workflow to Link Genetic Changes with Protein Variants with Proteograph™ Analysis Suite 2.0

Scalable, high-resolution, sample-specific analysis brings genomics and proteomics together to enable novel biological insights with the click of a button...

SEER : 2.0200 (+6.32%)

Business Summary

Seer Inc. is a life sciences company. It engages in developing Proteograph(TM), which is an integrated solution consisting of consumables, automation instrumentation and proprietary software. Seer Inc. is based in REDWOOD CITY, Calif.

See More

Key Turning Points

3rd Resistance Point 2.2133
2nd Resistance Point 2.1267
1st Resistance Point 2.0733
Last Price 2.0200
1st Support Level 1.9333
2nd Support Level 1.8467
3rd Support Level 1.7933

See More

52-Week High 2.3000
Last Price 2.0200
Fibonacci 61.8% 1.9772
Fibonacci 50% 1.8775
Fibonacci 38.2% 1.7778
52-Week Low 1.4550

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar